Corteva Inc. (CTVA) reported fourth-quarter 2025 revenue of $3.91 billion, down 1.7% year‑over‑year and below the consensus estimate of $4.32 billion.
The company recorded a net loss attributable to common shareholders of $552 million (improving by 1,246.3% YoY) and reported diluted earnings per share of -0.82 versus an estimate of 0.22.
Shares moved since market close by -3.92% following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Corteva Inc. Insider Trading Activity
Corteva Inc. insiders have traded $CTVA stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:
- ROBERT D. KING (EVP, Crop Protection Business) sold 37,280 shares for an estimated $2,765,993
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Corteva Inc. Hedge Fund Activity
We have seen 616 institutional investors add shares of Corteva Inc. stock to their portfolio, and 621 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 9,262,356 shares (+67.0%) to their portfolio in Q3 2025, for an estimated $626,413,136
- CAPITAL INTERNATIONAL INVESTORS removed 7,150,289 shares (-38.1%) from their portfolio in Q3 2025, for an estimated $483,574,045
- BLACKROCK, INC. added 6,379,354 shares (+12.7%) to their portfolio in Q3 2025, for an estimated $431,435,711
- NUVEEN, LLC removed 5,716,253 shares (-73.6%) from their portfolio in Q3 2025, for an estimated $386,590,190
- BESSEMER GROUP INC removed 3,536,542 shares (-97.7%) from their portfolio in Q3 2025, for an estimated $239,176,335
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,331,876 shares (+78.0%) to their portfolio in Q3 2025, for an estimated $225,334,773
- VAN ECK ASSOCIATES CORP removed 3,024,639 shares (-62.6%) from their portfolio in Q3 2025, for an estimated $204,556,335
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Corteva Inc. Analyst Ratings
Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/30/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- Argus Research issued a "Buy" rating on 10/13/2025
To track analyst ratings and price targets for Corteva Inc., check out Quiver Quantitative's $CTVA forecast page.
Corteva Inc. Price Targets
Multiple analysts have issued price targets for $CTVA recently. We have seen 10 analysts offer price targets for $CTVA in the last 6 months, with a median target of $79.0.
Here are some recent targets:
- Kristen Owen from Oppenheimer set a target price of $78.0 on 01/27/2026
- Patrick Cunningham from Citigroup set a target price of $74.0 on 01/21/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $75.0 on 01/21/2026
- Edlain Rodriguez from Mizuho set a target price of $80.0 on 01/16/2026
- Richard Garchitorena from Wells Fargo set a target price of $77.0 on 11/11/2025
- Joshua Spector from UBS set a target price of $81.0 on 10/30/2025
- Alexandra Yates from Argus Research set a target price of $80.0 on 10/13/2025
